Please select one: * I am in active clinical practice I am retired I am a student Other Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. * Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable 54321NA 54321NA The skills learned in this CME course enhanced my professional competence. The skills learned in this CME course enhanced my professional competence. - 5 The skills learned in this CME course enhanced my professional competence. - 4 The skills learned in this CME course enhanced my professional competence. - 3 The skills learned in this CME course enhanced my professional competence. - 2 The skills learned in this CME course enhanced my professional competence. - 1 The skills learned in this CME course enhanced my professional competence. - NA The skills learned in this CME course will be applied in the treatment of my patients The skills learned in this CME course will be applied in the treatment of my patients - 5 The skills learned in this CME course will be applied in the treatment of my patients - 4 The skills learned in this CME course will be applied in the treatment of my patients - 3 The skills learned in this CME course will be applied in the treatment of my patients - 2 The skills learned in this CME course will be applied in the treatment of my patients - 1 The skills learned in this CME course will be applied in the treatment of my patients - NA How confident are you in your ability to: * 5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence 54321 54321 Utilize the latest therapeutic advance for the treatment of AL amyloidosis. Utilize the latest therapeutic advance for the treatment of AL amyloidosis. - 5 Utilize the latest therapeutic advance for the treatment of AL amyloidosis. - 4 Utilize the latest therapeutic advance for the treatment of AL amyloidosis. - 3 Utilize the latest therapeutic advance for the treatment of AL amyloidosis. - 2 Utilize the latest therapeutic advance for the treatment of AL amyloidosis. - 1 Evaluate the eligibility criteria of ongoing clinical trials for AL amyloidosis to facilitate appropriate patient enrollment or referral. Evaluate the eligibility criteria of ongoing clinical trials for AL amyloidosis to facilitate appropriate patient enrollment or referral. - 5 Evaluate the eligibility criteria of ongoing clinical trials for AL amyloidosis to facilitate appropriate patient enrollment or referral. - 4 Evaluate the eligibility criteria of ongoing clinical trials for AL amyloidosis to facilitate appropriate patient enrollment or referral. - 3 Evaluate the eligibility criteria of ongoing clinical trials for AL amyloidosis to facilitate appropriate patient enrollment or referral. - 2 Evaluate the eligibility criteria of ongoing clinical trials for AL amyloidosis to facilitate appropriate patient enrollment or referral. - 1 How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? * Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied 54321 54321 Explain the pathophysiology of the plasma cell disorder AL amyloidosis to enhance understanding of disease mechanisms. Explain the pathophysiology of the plasma cell disorder AL amyloidosis to enhance understanding of disease mechanisms. - 5 Explain the pathophysiology of the plasma cell disorder AL amyloidosis to enhance understanding of disease mechanisms. - 4 Explain the pathophysiology of the plasma cell disorder AL amyloidosis to enhance understanding of disease mechanisms. - 3 Explain the pathophysiology of the plasma cell disorder AL amyloidosis to enhance understanding of disease mechanisms. - 2 Explain the pathophysiology of the plasma cell disorder AL amyloidosis to enhance understanding of disease mechanisms. - 1 Analyze recent data on therapeutic advances and evolving practice standards in AL amyloidosis and integrate this information into the selection of optimal systemic therapies for patients. Analyze recent data on therapeutic advances and evolving practice standards in AL amyloidosis and integrate this information into the selection of optimal systemic therapies for patients. - 5 Analyze recent data on therapeutic advances and evolving practice standards in AL amyloidosis and integrate this information into the selection of optimal systemic therapies for patients. - 4 Analyze recent data on therapeutic advances and evolving practice standards in AL amyloidosis and integrate this information into the selection of optimal systemic therapies for patients. - 3 Analyze recent data on therapeutic advances and evolving practice standards in AL amyloidosis and integrate this information into the selection of optimal systemic therapies for patients. - 2 Analyze recent data on therapeutic advances and evolving practice standards in AL amyloidosis and integrate this information into the selection of optimal systemic therapies for patients. - 1 Implement strategies to enhance patient-centered care. Implement strategies to enhance patient-centered care. - 5 Implement strategies to enhance patient-centered care. - 4 Implement strategies to enhance patient-centered care. - 3 Implement strategies to enhance patient-centered care. - 2 Implement strategies to enhance patient-centered care. - 1 Evaluate the design and eligibility criteria of ongoing clinical trials for AL amyloidosis and facilitate appropriate patient enrollment or referral. Evaluate the design and eligibility criteria of ongoing clinical trials for AL amyloidosis and facilitate appropriate patient enrollment or referral. - 5 Evaluate the design and eligibility criteria of ongoing clinical trials for AL amyloidosis and facilitate appropriate patient enrollment or referral. - 4 Evaluate the design and eligibility criteria of ongoing clinical trials for AL amyloidosis and facilitate appropriate patient enrollment or referral. - 3 Evaluate the design and eligibility criteria of ongoing clinical trials for AL amyloidosis and facilitate appropriate patient enrollment or referral. - 2 Evaluate the design and eligibility criteria of ongoing clinical trials for AL amyloidosis and facilitate appropriate patient enrollment or referral. - 1 Was this course fair, balanced and without commercial bias? * Yes No If you checked "No,” please explain why: * What, if any, new skills/strategies will you apply in your clinical practice? * If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? * Please provide any additional comments or suggestions. How did you hear about this course? * CME website Hospital-based Digital signage Email Google search Facebook LinkedIn Miami Medicine Journal CE Finder (CE Broker) CME Passport (ACCME) Other... How did you hear about this course? Other... Please select one: * M.D., D.O. Ph.D/Psy.D APRN/PA-C R.N. Dietitian Social Worker/MHC/MFT Pharmacist Respiratory Other... Please select one: Other... Name Leave this field blank
